arrow
A

Aayushi Mahajan

Cornell University
H指数:18
被引数:2,442

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Convection-Enhanced Delivery of Topotecan Induces IL-1β-Associated Inflammation in Glioblastoma

拓扑替康的增强对流递送诱导胶质母细胞瘤中IL-1β相关的炎症

2026-04-010
PRE
Convection-enhanced delivery of dexamethasone potently suppresses glioma-associated inflammation in a mechanistically distinct way from systemic drug delivery

经增强的右美托咪定对流输送可显著抑制胶质瘤相关的炎症,其机制与全身性药物输送不同。

2025-11-010
OAAI
HUMAN AND MOUSE PERITUMORAL SLICES DEMONSTRATE MTOR-DEPENDENT GABAERGIC NEURONAL DYSFUNCTION IN GLIOMA

人源和鼠源肿瘤周切片显示胶质瘤中存在mTOR依赖的GABA能神经元功能障碍

2025-11-010
OAAI
Intraoperative 5-Aminolevulinic Acid (5ALA) fluorescence distinguishes cellular composition and immunogenicity in the infiltrating margin of Glioblastoma

术中5-氨基乙酰丙酸(5ALA)荧光可区分胶质母细胞瘤浸润边缘的细胞组成和免疫原性。

2025-11-010
OAAI
PROMINENT GLIOMA CALCIUM TRANSIENTS CAN BE REPEATEDLY TRIGGERED BY STIMULUS-EVOKED NEURONAL ACTIVITY AND PURINERGIC SIGNALING

显著胶质瘤钙瞬变可被刺激诱发的神经元活动和嘌呤能信号反复触发。

2025-11-010
PRE
IDH1(R132H) inhibitors enhance the sensitivity of IDH1-mutant glioma to cysteine deprivation and ferroptosis

IDH1(R132H)抑制剂增强了IDH1突变型胶质瘤对半胱氨酸剥夺和铁死亡的敏感性。

2025-11-010
OAAI
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition

胶质瘤诱导的兴奋性神经元改变可通过mTOR抑制得到逆转

NEURON
IF15
2025-01-010
PRE
CHEMOTHERAPY INDUCED IMMUNOGENIC RESPONSE IN GLIOMA AND IMPLICATIONS FOR THERAPEUTIC STRATEGIES
2024-11-110
PRE
A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma
2024-08-271
OAAI
Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state
2024-08-080
OAAI
Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator
2024-06-250
OAAI
Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons
2024-05-011
OAAI
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states
2023-05-0422
OAAI